Kato Hideaki, Orito Etsuro, Sugauchi Fuminaka, Ueda Ryuzo, Koshizaka Takuya, Yanaka Shoko, Gish Robert G, Kurbanov Fuat, Ruzibakiev Ruslan, Kramvis Anna, Kew Michael C, Ahmad Nooruddin, Khan Mobin, Usuda Sadakazu, Miyakawa Yuzo, Mizokami Masashi
Department of Clinical Molecular Informative Medicine, Nagoya City University Graduate School of Medical Sciences, 467-8601, Nagoya, Japan.
J Virol Methods. 2003 Jun 9;110(1):29-35. doi: 10.1016/s0166-0934(03)00095-8.
A genotype-specific probes assay (GSPA) was developed for distinguishing the seven genotypes (A-G) of hepatitis B virus (HBV). Nucleotide (nt) sequences corresponding to preS1 region were amplified by PCR with a primer labeled with biotin, and delivered to eight wells on which complementary sequences specific to one or other genotype had been immobilized. Thereafter, hybridization of HBV DNA sequences amplified from the test serum was detected by colorimetry. When 256 sera from HBV carriers in Bangladesh, Cameroon, Japan, South Africa, USA and Uzbekistan were subjected to GSPA, genotypes were concordant with those of ELISA with monoclonal antibodies to epitopes on preS2-region products in 242 (94.6%) of them; 8 sera (3.1%) were not genotypeable by either method. Cloning analysis confirmed the presence of two distinct HBV genotypes in the seven selected sera with coinfection. There were 7 (2.7%) sera with discordant genotyping results between GSPA and ELISA. When HBV DNA clones propagated from these sera were sequenced and analyzed phylogenetically, the genotypes determined by GSPA were verified. Coinfection with HBV strains of two distinct genotypes was identified by GSPA in 28 (10.9%) sera, while it was suggested by ELISA in only 2 (0.8%) sera. The GSPA method would be particularly useful for detecting the coinfection with distinct HBV genotypes of any clinical relevance, which seems to be more frequent than reported previously.
开发了一种基因型特异性探针检测法(GSPA),用于区分乙型肝炎病毒(HBV)的七种基因型(A - G)。用生物素标记的引物通过聚合酶链反应(PCR)扩增与前S1区对应的核苷酸(nt)序列,并将其加到八个孔中,孔上固定有针对一种或另一种基因型的互补序列。此后,通过比色法检测从测试血清中扩增的HBV DNA序列的杂交情况。当对来自孟加拉国、喀麦隆、日本、南非、美国和乌兹别克斯坦的256例HBV携带者血清进行GSPA检测时,其中242例(94.6%)的基因型与用针对前S2区产物表位的单克隆抗体进行酶联免疫吸附测定(ELISA)的结果一致;8例血清(3.1%)用两种方法均无法进行基因分型。克隆分析证实了7例选定的合并感染血清中存在两种不同的HBV基因型。有7例血清(2.7%)的GSPA和ELISA基因分型结果不一致。对这些血清中扩增的HBV DNA克隆进行测序并进行系统发育分析时,证实了GSPA确定的基因型。GSPA在28例(10.9%)血清中鉴定出两种不同基因型的HBV毒株合并感染,而ELISA仅在2例(0.8%)血清中提示有合并感染。GSPA方法对于检测具有任何临床相关性的不同HBV基因型的合并感染特别有用,这种合并感染似乎比以前报道的更为常见。